Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...

Zydus Lifesciences Limited (“Zydus”) has entered into exclusive negotiations to purchase a controlling 85.6 percent stake in ...

Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...

Eluxadoline tablets will be produced at Zydus Lifesciences Ltd (SEZ) in Ahmedabad, the company said in an exchange filing.

On March 18, post-market hours, Zydus Lifesciences announced that it has received approval from the United States Food & Drug ...